Literature DB >> 18789389

Appearance modeling of 11C PiB PET images: characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy aging.

Jurgen Fripp1, Pierrick Bourgeat, Oscar Acosta, Parnesh Raniga, Marc Modat, Kerryn E Pike, Gareth Jones, Graeme O'Keefe, Colin L Masters, David Ames, Kathryn A Ellis, Paul Maruff, Jon Currie, Victor L Villemagne, Christopher C Rowe, Olivier Salvado, Sébastien Ourselin.   

Abstract

Beta-amyloid (Abeta) deposition is one of the neuropathological hallmarks of Alzheimer's disease (AD), Abeta burden can be quantified using (11)C PiB PET. Neuropathological studies have shown that the initial plaques are located in the temporal and orbitofrontal cortices, extending later to the cingulate, frontal and parietal cortices (Braak and Braak, 1997). Previous studies have shown an overlap in (11)C PiB PET retention between AD, mild cognitive impairment (MCI) patients and normal elderly control (NC) participants. It has also been shown that there is a relationship between Abeta deposition and memory impairment in MCI patients. In this paper we explored the variability seen in 15 AD, 15 MCI and 18 NC by modeling the voxel data from spatially and uptake normalized PiB images using principal component analysis. The first two principal components accounted for 80% of the variability seen in the data, providing a clear separation between AD and NC, and allowing subsequent classification. The MCI cases were distributed along an apparent axis between the AD and NC group, closely aligned with the first principal component axis. The NC cases that were PiB(+) formed a distinct cluster that was between, but separated from the AD and PiB(-) NC clusters. The PiB(+) MCI were found to cluster with the AD cases, and exhibited a similar deposition pattern. The primary principal component score was found to correlate with episodic memory scores and mini mental status examination and it was observed that by varying the first principal component, a change in amyloid deposition could be derived that is similar to the expected progression of amyloid deposition observed from post mortem studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18789389     DOI: 10.1016/j.neuroimage.2008.07.053

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  27 in total

Review 1.  Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia.

Authors:  William E Klunk
Journal:  Neurobiol Aging       Date:  2011-12       Impact factor: 4.673

2.  Translational medicine lessons from flurizan's failure in Alzheimer's disease (AD) trial: Implication for future drug discovery and development for AD.

Authors:  Hong I Wan; J Steve Jacobsen; J Lynn Rutkowski; Giora Z Feuerstein
Journal:  Clin Transl Sci       Date:  2009-06       Impact factor: 4.689

3.  Correlation of early-phase 18F-florbetapir (AV-45/Amyvid) PET images to FDG images: preliminary studies.

Authors:  Ing-Tsung Hsiao; Chin-Chang Huang; Chia-Ju Hsieh; Wen-Chun Hsu; Shiaw-Pyng Wey; Tzu-Chen Yen; Mei-Ping Kung; Kun-Ju Lin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-01-21       Impact factor: 9.236

4.  Tau and Amyloid-β Cerebrospinal Fluid Biomarkers have Differential Relationships with Cognition in Mild Cognitive Impairment.

Authors:  Charles B Malpas; Michael M Saling; Dennis Velakoulis; Patricia Desmond; Terence J O'Brien
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 5.  Clinical applications of PET amyloid imaging: an update.

Authors:  Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-07       Impact factor: 9.236

6.  Not quite PIB-positive, not quite PIB-negative: slight PIB elevations in elderly normal control subjects are biologically relevant.

Authors:  Elizabeth C Mormino; Michael G Brandel; Cindee M Madison; Gil D Rabinovici; Shawn Marks; Suzanne L Baker; William J Jagust
Journal:  Neuroimage       Date:  2011-08-22       Impact factor: 6.556

Review 7.  Detectable Neuropsychological Differences in Early Preclinical Alzheimer's Disease: A Meta-Analysis.

Authors:  S Duke Han; Caroline P Nguyen; Nikki H Stricker; Daniel A Nation
Journal:  Neuropsychol Rev       Date:  2017-05-11       Impact factor: 7.444

8.  Optimized data preprocessing for multivariate analysis applied to 99mTc-ECD SPECT data sets of Alzheimer's patients and asymptomatic controls.

Authors:  Dorit Merhof; Pawel J Markiewicz; Günther Platsch; Jerome Declerck; Markus Weih; Johannes Kornhuber; Torsten Kuwert; Julian C Matthews; Karl Herholz
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-14       Impact factor: 6.200

Review 9.  Beta-amyloid deposition and the aging brain.

Authors:  Karen M Rodrigue; Kristen M Kennedy; Denise C Park
Journal:  Neuropsychol Rev       Date:  2009-11-12       Impact factor: 7.444

10.  Superior memory and higher cortical volumes in unusually successful cognitive aging.

Authors:  Theresa M Harrison; Sandra Weintraub; M-Marsel Mesulam; Emily Rogalski
Journal:  J Int Neuropsychol Soc       Date:  2012-11       Impact factor: 2.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.